Skip to main content

Advertisement

SpringerLink
Log in

State-of-the-art surgery for Crohn’s disease: Part I—small intestine/ileal disease

  • State-of-the-Art Clinical Surgery
  • Published:
Langenbeck's Archives of Surgery Aims and scope Submit manuscript

Abstract

The management of Crohn’s disease has evolved significantly over the past 20 years. The arrival of biologic therapies has altered not only the management and outcomes but also rates for refractory disease requiring surgery. New surgical techniques have paralleled these medical advances, and this article will provide an overview of these new modalities as well as their outcomes. This is the first of a three-part series and will focus on terminal ileal and ileocolic disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Crohn BB, Ginzburg L, Oppenheimer GD (1932) Regional ileitis: a pathologic and clinical entity. J Am Med Assoc 99:1323–1329. https://doi.org/10.1001/jama.1932.02740680019005

    Article  Google Scholar 

  2. Ng SC, Shi HY, Hamidi N et al (2017) Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet 390:2769–2778. https://doi.org/10.1016/S0140-6736(17)32448-0

    Article  PubMed  Google Scholar 

  3. Satsangi J, Silverberg MS, Vermeire S, Colombel J-F (2006) The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 55:749–753. https://doi.org/10.1136/gut.2005.082909

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Polito JM II, Childs B, Mellits ED, Tokayer AZ, Harris ML, Bayless TM (1996) Crohn’s disease: influence of age at diagnosis on site and clinical type of disease. Gastroenterology 111:580–586. https://doi.org/10.1053/gast.1996.v111.pm8780560

    Article  PubMed  Google Scholar 

  5. Elloumi H, Sfar S, Ben Abdelaziz A, Arfaoui D, Mouna G, Ajmi S (2007) Crohn’s disease: influence of age at diagnosis on clinical type of disease. Tunis Med 85:862–865

    PubMed  Google Scholar 

  6. Hanauer SB, Feagan BG, Lichtenstein GR, ACCENT I Study Group et al (2002) Maintenance infliximab for Crohn’s disease: the ACCENT I randomised trial. Lancet. 359:1541–1549. https://doi.org/10.1016/S0140-6736(02)08512-4

    Article  CAS  PubMed  Google Scholar 

  7. European Medicines Agency. https://www.ema.europa.eu/en. Accessed August 1, 2021

  8. Ye BD, Pesegova M, Alexeeva O et al (2019) Efficacy and safety of biosimilar CT-P13 compared with originator infliximab in patients with active Crohn’s disease: an international, randomised, double-blind, phase 3 non-inferiority study. Lancet 393:1699–1707. https://doi.org/10.1016/S0140-6736(18)32196-2

    Article  CAS  PubMed  Google Scholar 

  9. Lukas M, Malickova K, Kolar M et al (2020) Switching from originator adalimumab to the biosimilar SB5 in patients with inflammatory bowel disease: short-term experience from a single tertiary clinical centre. J Crohns Colitis 14:915–919. https://doi.org/10.1093/ecco-jcc/jjaa001

    Article  PubMed  Google Scholar 

  10. Ribaldone DG, Caviglia GP, Pellicano R et al (2020) Effectiveness and safety of adalimumab biosimilar ABP 501 in Crohn’s disease: an observational study. Rev Esp Enferm Dig 112(3):195–200. https://doi.org/10.17235/reed.2020.6693/2019

    Article  PubMed  Google Scholar 

  11. Haifer C, Srinivasan A, An Y-K et al (2021) Switching Australian patients with moderate to severe inflammatory bowel disease from originator to biosimilar infliximab: a multicentre, parallel cohort study. Med J Aust 214:128–133. https://doi.org/10.5694/mja2.50824

    Article  PubMed  Google Scholar 

  12. De Cruz P, Kamm MA, Prideaux L, Allen PB, Desmond PV (2012) Postoperative recurrent luminal Crohn’s disease: a systematic review. Inflamm Bowel Dis 18:758–777. https://doi.org/10.1002/ibd.21825

    Article  PubMed  Google Scholar 

  13. Frolkis AD, Dykeman J, Negrón ME et al (2013) Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies. Gastroenterology 145:996–1006. https://doi.org/10.1053/j.gastro.2013.07.041

    Article  PubMed  Google Scholar 

  14. Elsayes KM, Al-Hawary MM, Jagdish J, Ganesh HS, Platt JF (2010) CT enterography: principles, trends, and interpretation of findings. Radiographics 30:1955–1970. https://doi.org/10.1148/rg.307105052

    Article  PubMed  Google Scholar 

  15. Estay C, Simian D, Lubascher J, Figueroa C, O’Brien A, Quera R (2015) Ionizing radiation exposure in patients with inflammatory bowel disease: are we overexposing our patients? J Dig Dis 16:83–89. https://doi.org/10.1111/1751-2980.12213

    Article  PubMed  Google Scholar 

  16. Jung YS, Park DI, Kim ER et al (2013) Quantifying exposure to diagnostic radiation and factors associated with exposure to high levels of radiation in Korean patients with inflammatory bowel disease. Inflamm Bowel Dis 19:1852–1857. https://doi.org/10.1097/MIB.0b013e31828c844f

    Article  PubMed  Google Scholar 

  17. Fazio VW, Marchetti F, Church M et al (1996) Effect of resection margins on the recurrence of Crohn’s disease in the small bowel. A randomized controlled trial. Ann Surg 224:563–571. https://doi.org/10.1097/00000658-199610000-00014

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Zemel M, Solo E, Tulchinsky H (2021) Does microscopic involvement of the surgical margins after ileocecectomy in Crohn’s patients predict early recurrence? Int J Colorectal Dis. https://doi.org/10.1007/s00384-021-03941-7

    Article  PubMed  Google Scholar 

  19. Ryan JM, Rogers AC, O’Toole A, Burke JP (2019) Meta-analysis of histological margin positivity in the prediction of recurrence after Crohn’s resection. Dis Colon Rectum 62:882–892. https://doi.org/10.1097/DCR.0000000000001407

    Article  PubMed  Google Scholar 

  20. Hammoudi N, Cazals-Hatem D, Auzolle C, REMIND Study Group Investigators et al (2020) Association between microscopic lesions at ileal resection margin and recurrence after surgery in patients with Crohn’s disease. Clin Gastroenterol Hepatol 18:141-149.e2. https://doi.org/10.1016/j.cgh.2019.04.045

    Article  PubMed  Google Scholar 

  21. Coffey CJ, Kiernan MG, Sahebally SM et al (2018) Inclusion of the mesentery in ileocolic resection for Crohn’s disease is associated with reduced surgical recurrence. J Crohns Colitis 12:1139–1150. https://doi.org/10.1093/ecco-jcc/jjx187

    Article  PubMed  PubMed Central  Google Scholar 

  22. Borley NR, Mortensen NJ, Jewell DP, Warren BF (2000) The relationship between inflammatory and serosal connective tissue changes in ileal Crohn’s disease: evidence for a possible causative link. J Pathol 190:196–202. https://doi.org/10.1002/(SICI)1096-9896(200002)190:2%3c196:AID-PATH513%3e3.0.CO;2-5

    Article  CAS  PubMed  Google Scholar 

  23. Li Y, Mohan H, Lan N et al (2020) Mesenteric excision surgery or conservative limited resection in Crohn’s disease: study protocol for an international, multicenter, randomized controlled trial. Trials 21:210. https://doi.org/10.1186/s13063-020-4105-x

    Article  PubMed  PubMed Central  Google Scholar 

  24. Pironi L, Arends J, Bozzetti F, Home artificial nutrition & chronic intestinal failure special interest group of ESPEN et al (2016) ESPEN guidelines on chronic intestinal failure in adults. Clin Nutr 35:247–307. https://doi.org/10.1016/j.clnu.2016.01.020

    Article  PubMed  Google Scholar 

  25. Baca B, Ozben V, Boler DE et al (2010) Effect of corticosteroid dose and duration of administration on colonic anastomosis. Inflamm Bowel Dis 16:2162–2167. https://doi.org/10.1002/ibd.21331

    Article  PubMed  Google Scholar 

  26. Bischoff SC, Escher J, Hébuterne X et al (2020) ESPEN practical guideline: clinical nutrition in inflammatory bowel disease. Clin Nutr 39:632–653. https://doi.org/10.1016/j.clnu.2019.11.002

    Article  PubMed  Google Scholar 

  27. Campos FG, Waitzberg DL, Teixeira MG, Mucerino DR, Kiss DR, Habr-Gama A (2003) Pharmacological nutrition in inflammatory bowel diseases. Nutr Hosp 18:57–64

    CAS  PubMed  Google Scholar 

  28. Michelassi F (1996) Side-to-side isoperistaltic strictureplasty for multiple Crohn’s strictures. Dis Colon Rectum 39:345–349. https://doi.org/10.1007/BF02049480

    Article  CAS  PubMed  Google Scholar 

  29. Mege D, Michelassi F, Michelassi II (2020) Michelassi II strictureplasty for Crohn’s disease: a new side-to-side isoperistaltic strictureplasty with discontinuous bowel loops. Ann Surg 271:e1–e2. https://doi.org/10.1097/SLA.0000000000003430

    Article  PubMed  Google Scholar 

  30. Yamamoto T, Fazio VW, Tekkis PP (2007) Safety and efficacy of strictureplasty for Crohn’s disease: a systematic review and meta-analysis. Dis Colon Rectum 50:1968–1986. https://doi.org/10.1007/s10350-007-0279-5

    Article  PubMed  Google Scholar 

  31. Dietz DW, Laureti S, Strong SA et al (2001) Safety and longterm efficacy of strictureplasty in 314 patients with obstructing small bowel Crohn’s disease. J Am Coll Surg 192:330–337. https://doi.org/10.1016/s1072-7515(01)00775-x

    Article  CAS  PubMed  Google Scholar 

  32. Celentano V, Beable R, Ball C et al (2020) Feasibility of intraoperative ultrasound of the small bowel during Crohn’s disease surgery. Tech Coloproctol 24:965–969. https://doi.org/10.1007/s10151-020-02268-9

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M (1990) Predictability of the postoperative course of Crohn’s disease. Gastroenterology 99:956–963. https://doi.org/10.1016/0016-5085(90)90613-6

    Article  CAS  PubMed  Google Scholar 

  34. Resegotti A, Astegiano M, Farina EC et al (2005) Side-to-side stapled anastomosis strongly reduces anastomotic leak rates in Crohn’s disease surgery. Dis Colon Rectum 48:464–468. https://doi.org/10.1007/s10350-004-0786-6

    Article  PubMed  Google Scholar 

  35. He X, Chen Z, Huang J et al (2014) Stapled side-to-side anastomosis might be better than handsewn end-to-end anastomosis in ileocolic resection for Crohn’s disease: a meta-analysis. Dig Dis Sci 59:1544–1551. https://doi.org/10.1007/s10620-014-3039-0

    Article  PubMed  Google Scholar 

  36. Kono T, Ashida T, Ebisawa Y et al (2011) A new antimesenteric functional end-to-end handsewn anastomosis: surgical prevention of anastomotic recurrence in Crohn’s disease. Dis Colon Rectum 54:586–592. https://doi.org/10.1007/DCR.0b013e318208b90f

    Article  PubMed  Google Scholar 

  37. Kono T, Fichera A (2020) Surgical treatment for Crohn’s disease: a role of Kono-S anastomosis in the west. Clin Colon Rectal Surg 33:335–343. https://doi.org/10.1055/s-0040-1714236

    Article  PubMed  PubMed Central  Google Scholar 

  38. Fornaro R, Caristo G, Stratta E et al (2019) Crohn’s disease and postoperative recurrence. The role of anastomotic configurations and the Kono-s anastomosis. Ann Ital Chir 90:111–120

    PubMed  Google Scholar 

  39. Shimada N, Ohge H, Kono T et al (2019) Surgical recurrence at anastomotic site after bowel resection in Crohn’s disease: comparison of Kono-S and end-to-end anastomosis. J Gastrointest Surg 23:312–319. https://doi.org/10.1007/s11605-018-4012-6

    Article  PubMed  Google Scholar 

  40. Kono T, Fichera A, Maeda K et al (2016) Kono-S Anastomosis for surgical prophylaxis of anastomotic recurrence in Crohn’s disease: an international multicenter study. J Gastrointest Surg 20:783–790. https://doi.org/10.1007/s11605-015-3061-3

    Article  PubMed  Google Scholar 

  41. Alshantti A, Hind D, Hancock L, Brown SR (2021) The role of Kono-S anastomosis and mesenteric resection in reducing recurrence after surgery for Crohn’s disease: a systematic review. Colorectal Dis 23:7–17. https://doi.org/10.1111/codi.15136

    Article  CAS  PubMed  Google Scholar 

  42. Rutgeerts P, Goboes K, Peeters M et al (1991) Effect of faecal stream diversion on recurrence of Crohn’s disease in the neoterminal ileum. Lancet 338:771–774. https://doi.org/10.1016/0140-6736(91)90663-a

    Article  CAS  PubMed  Google Scholar 

  43. Onali S, Calabrese E, Petruzziello C et al (2016) Post-operative recurrence of Crohn’s disease: a prospective study at 5 years. Dig Liver Dis 48(5):489–494. https://doi.org/10.1016/j.dld.2016.01.009

    Article  PubMed  Google Scholar 

  44. Regueiro M, Schraut W, Baidoo L et al (2009) Infliximab prevents Crohn’s disease recurrence after ileal resection. Gastroenterology 136:441–50.e1. https://doi.org/10.1053/j.gastro.2008.10.051

    Article  CAS  PubMed  Google Scholar 

  45. Armuzzi A, Felice C, Papa A et al (2013) Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn’s disease: an open-label pilot study. J Crohns Colitis 7:e623–e629. https://doi.org/10.1016/j.crohns.2013.04.020

    Article  PubMed  Google Scholar 

  46. Savarino E, Bodini G, Dulbecco P et al (2013) Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn’s disease: a randomized controlled trial. Am J Gastroenterol 108:1731–1742. https://doi.org/10.1038/ajg.2013.287

    Article  CAS  PubMed  Google Scholar 

  47. Neary PM, Aiello AC, Stocchi L et al (2019) High-risk ileocolic anastomoses for Crohn’s disease: when is diversion indicated? J Crohns Colitis 13:856–863. https://doi.org/10.1093/ecco-jcc/jjz004

    Article  PubMed  Google Scholar 

  48. Telem DA, Chin EH, Nguyen SQ, Divino CM (2010) Risk factors for anastomotic leak following colorectal surgery: a case-control study. Arch Surg 145:371–376. https://doi.org/10.1001/archsurg.2010.40

    Article  PubMed  Google Scholar 

  49. Tzivanakis A, Singh JC, Guy RJ, Travis SPL, Mortensen NJ, George BD (2012) Influence of risk factors on the safety of ileocolic anastomosis in Crohn’s disease surgery. Dis Colon Rectum 55:558–562. https://doi.org/10.1097/DCR.0b013e318247c433

    Article  CAS  PubMed  Google Scholar 

  50. Ponsioen CY, de Groof EJ, Eshuis EJ, LIR!C study group et al (2017) Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn’s disease: a randomised controlled, open-label, multicentre trial. Lancet Gastroenterol Hepatol 2:785–792. https://doi.org/10.1016/S2468-1253(17)30248-0

    Article  PubMed  Google Scholar 

  51. Stevens TW, Haasnoot ML, D’Haens GR, LIR!C study group et al (2020) Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn’s disease: retrospective long-term follow-up of the LIR!C trial. Lancet Gastroenterol Hepatol 5:900–907. https://doi.org/10.1016/S2468-1253(20)30117-5

    Article  PubMed  Google Scholar 

  52. de Groof EJ, Stevens TW, Eshuis EJ, LIR!C study group et al (2019) Cost-effectiveness of laparoscopic ileocaecal resection versus infliximab treatment of terminal ileitis in Crohn’s disease: the LIR!C Trial. Gut 68:1774–1780. https://doi.org/10.1136/gutjnl-2018-317539

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Colon & Rectal Surgery, Hiram C. Polk Jr. MD Department of Surgery, 550 South Jackson Street, Louisville, KY, 40202, USA

    Sandra L. Kavalukas & Susan Galandiuk

  2. Hiram C. Polk Jr. MD Department of Surgery, Price Institute of Surgical Research, University of Louisville, Louisville, KY, 40292, USA

    Sandra L. Kavalukas, Katharina M. Scheurlen & Susan Galandiuk

Authors
  1. Sandra L. Kavalukas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Katharina M. Scheurlen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Susan Galandiuk
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Susan Galandiuk.

Ethics declarations

Conflict of interest

Drs. Kavalukas and Scheurlen have no conflict of interest. Dr. Galandiuk is the Editor-in-Chief of Diseases of the Colon and Rectum and is the Director of the Price Institute of Surgical Research and receives support from AbbVie for clinical research.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kavalukas, S.L., Scheurlen, K.M. & Galandiuk, S. State-of-the-art surgery for Crohn’s disease: Part I—small intestine/ileal disease. Langenbecks Arch Surg 407, 885–895 (2022). https://doi.org/10.1007/s00423-021-02324-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00423-021-02324-4

Keywords

Search

Navigation